Targeting AMPK signaling in diabetic wounds facilitates the healing process

Kankan Roy1, Bapi Gorain1

  • 1Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi 835215, India.

Drug Discovery Today
|November 7, 2025
PubMed

Insights

Diabetic wound healing is impaired by complications. This review explores how 5'-adenosine monophosphate-activated protein kinase (AMPK) influences cellular processes vital for healing in diabetic patients.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Diabetology

Background:

  • Diabetes complications, including micro- and macrovascular issues, significantly impede wound healing.
  • Delayed wound healing in diabetic patients can lead to severe outcomes such as limb amputations.
  • 5 - adenosine monophosphate-activated protein kinase (AMPK) is crucial for cellular energy homeostasis and insulin sensitivity.

Purpose of the Study:

  • To review the current understanding of AMPK's physiological and pathological roles in the context of diabetic wound healing.
  • To elucidate the mechanisms by which AMPK influences key cellular processes involved in wound repair.

Main Methods:

  • Literature review of studies investigating AMPK in diabetic wound environments.
  • Analysis of molecular and physiological pathways regulated by AMPK.
  • Synthesis of current knowledge on AMPK's impact on angiogenesis, cell communication, migration, and proliferation.

Main Results:

  • AMPK activation influences cellular energy metabolism and insulin signaling pathways.
  • AMPK plays a multifaceted role in regulating angiogenesis, cell migration, and proliferation within the diabetic wound milieu.
  • Dysregulation of AMPK can exacerbate impaired healing processes in diabetes.

Conclusions:

  • Understanding AMPK's role is critical for developing effective therapeutic strategies for diabetic wound healing.
  • Targeting AMPK pathways may offer a promising approach to improve wound repair in diabetic patients.
  • Further research into AMPK's specific molecular targets and regulatory networks is warranted.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K